Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Profession Business and Innovation, Professional Development, Health Economics and Policy, Retina, Glaucoma, Education and Training, COVID-19

Stronger Together

Charles Holmes and Ignacio Tuduri on the Allergan AbbVie vision for the future – post-merger

Aleksandra Jones | | Interview

In May 2020 Allergan merged with AbbVie, the global research-based biopharmaceutical company. We caught up with Charles Holmes, Associate Vice President, Head of Global Marketing, Eyecare at Allergan, who is based in the UK, and Ignacio Tuduri, Vice President, Global Marketing at AbbVie, based in Chicago, Illinois, USA, to ask about the integration, their experience in the field, addressing unmet needs in ophthalmology, and current and future projects.

Read the full article now

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!

Login

Forgot your password?

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

Business & Profession Business and Innovation, Professional Development, Health Economics and Policy, Retina, Glaucoma, Education and Training, COVID-19

About the Author

Aleksandra Jones

Editor of The Ophthalmologist

Having edited several technical publications over the last decade, I crossed paths with quite a few of Texere's current team members, and I only ever heard them sing the company's praises. When an opportunity arose to join Texere, I jumped at the chance! With a background in literature, I love the company's ethos of producing genuinely engaging content, and the fact that it is so well received by our readers makes it even more rewarding.

Related Webinar

Business & Profession Cataract

Real World Evidence in Cataract Surgery: IOL material can affect PCO and Nd:Yag treatments

| Sponsored by Alcon

Newsletter

Send me the latest from The Ophthalmologist.

Sign up now

Most Popular

1.

COVID-19 and Dry Eye Disease

| Sponsored by Santen Pharmaceuticals

2. Business & Profession Other

Don’t Disrespect Diamox

| Mark Hillen

3. Subspecialties Cataract

The Misnomer of Monovision

| Ray Radford

4. Subspecialties COVID-19

Caution: Surgeons at Risk

| John Liu, Irfan Nizarali Kherani, Ike Ahmed

5. Subspecialties Refractive

Defusing the Myopia Time-Bomb

| Bhavin Shah

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

December Issue of The Ophthalmologist